Chlorthalidone is a long-acting diuretic (water pill) used primarily to treat high blood pressure. It’s one of three thiazide-type diuretics recommended as a first-line treatment for hypertension by the American Heart Association and American College of Cardiology, and it has been a cornerstone of blood pressure management for over 60 years. It’s also prescribed to reduce fluid retention (edema) and, in some cases, to help prevent recurrent kidney stones.
How Chlorthalidone Works
Chlorthalidone acts on a specific part of your kidneys called the distal tubule, where it blocks the reabsorption of sodium and water back into your bloodstream. The result: your body excretes more salt and water through urine, which lowers the volume of fluid in your blood vessels and brings down blood pressure.
What sets chlorthalidone apart from its close relative hydrochlorothiazide (HCTZ) is how long it stays active. A single dose of chlorthalidone has a half-life of roughly 40 hours, compared to about 6 to 9 hours for HCTZ. With long-term use, chlorthalidone’s half-life extends to 45 to 60 hours, and its blood-pressure-lowering effect can last 48 to 72 hours. HCTZ, by comparison, lasts 16 to 24 hours with ongoing use. This means chlorthalidone provides steadier blood pressure control throughout the day and night, which is particularly useful since blood pressure naturally spikes in the early morning hours.
Treating High Blood Pressure
Chlorthalidone’s primary use is lowering blood pressure to reduce the risk of heart attack, stroke, and heart failure. The 2025 AHA/ACC guidelines list thiazide-type diuretics alongside calcium channel blockers and two other drug classes as the four recommended first-line options for hypertension, based on strong clinical trial evidence showing they lower blood pressure effectively, prevent cardiovascular events, and are generally well tolerated.
The landmark ALLHAT trial, one of the largest blood pressure studies ever conducted, used chlorthalidone as its diuretic arm. The trial concluded that thiazide-type diuretics are “unsurpassed in lowering BP, reducing clinical events, and tolerability” and are less costly than alternatives. For patients whose blood pressure remains stubbornly high despite multiple medications (a condition called resistant hypertension), current guidelines specifically prefer longer-acting diuretics like chlorthalidone over shorter-acting ones because of their greater efficacy.
The typical starting dose for blood pressure is 12.5 to 15 mg once daily, taken with food. If blood pressure doesn’t drop enough after two weeks, the dose can be increased to 25 mg daily. Doses above 25 mg generally don’t lower blood pressure further but do increase the likelihood of side effects.
Reducing Fluid Retention
Chlorthalidone is also approved to treat edema, the buildup of excess fluid in body tissues that causes swelling, often in the legs, ankles, or feet. Edema can stem from heart failure, liver disease, kidney problems, or certain medications. The doses used for edema are higher than for blood pressure: typically 50 to 100 mg daily to start, with a maximum of 200 mg per day depending on how well you respond.
Preventing Kidney Stones
People who form calcium-based kidney stones repeatedly are sometimes prescribed chlorthalidone to reduce the amount of calcium their kidneys release into urine. Less calcium in the urine means lower supersaturation of calcium oxalate and calcium phosphate, the two mineral combinations that form most kidney stones.
Research published in the Journal of Urology found that 25 mg of chlorthalidone taken in the morning reduced urinary calcium excretion from 130 mg per gram of creatinine to 76 mg per gram, a roughly 40% drop. Chlorthalidone showed a more robust calcium-lowering effect than HCTZ, which aligns with its longer duration of action. Morning dosing appeared more effective than evening dosing for this purpose.
Chlorthalidone vs. Hydrochlorothiazide
These two diuretics are frequently compared because they work similarly but differ in potency and duration. Chlorthalidone is more potent on a milligram-for-milligram basis, which is why a typical chlorthalidone dose (12.5 to 25 mg) is lower than a typical HCTZ dose (25 to 50 mg). For years, many experts assumed chlorthalidone’s longer action and greater potency would translate into better cardiovascular protection.
The Diuretic Comparison Project, a large trial comparing the two drugs head-to-head, produced a more nuanced picture. When researchers estimated what would happen if every patient took their assigned medication continuously for five years, the rate of major cardiovascular events was 15% with HCTZ and 20% with chlorthalidone. That difference, however, was not statistically significant, meaning the study couldn’t confirm a true advantage for either drug. A subgroup of patients who already had cardiovascular disease did appear to benefit more from chlorthalidone, but the trial’s design made it hard to draw firm conclusions from that finding alone.
The practical takeaway: both drugs are effective for blood pressure control. Chlorthalidone may be a better fit when longer-lasting, more consistent blood pressure reduction is needed, while HCTZ may carry a lower risk of certain metabolic side effects.
Common Side Effects
The most clinically important side effect of chlorthalidone is low potassium (hypokalemia). A large observational study from the OHDSI research network found that 6.3% of patients taking chlorthalidone developed low potassium, compared to 1.9% of those on HCTZ. Low potassium can cause muscle cramps, weakness, and fatigue, and in more severe cases it can trigger abnormal heart rhythms. Your doctor will typically check your potassium levels through blood work after starting the medication and periodically thereafter.
Chlorthalidone also carries a higher risk of low sodium (hyponatremia) than HCTZ. Low sodium can cause confusion, headaches, nausea, and in severe cases, seizures. Other potential issues include elevated blood sugar levels, with some patients developing type 2 diabetes over time, as well as elevated uric acid, which can trigger gout flares in people who are already prone to the condition. Some patients also experience kidney function changes.
Because chlorthalidone increases urination, you’ll likely notice more frequent trips to the bathroom, especially in the first few weeks. Taking the medication in the morning helps avoid nighttime disruptions.
Who Should Avoid Chlorthalidone
Chlorthalidone is not appropriate for people who are unable to urinate or have severe difficulty urinating. If you have a history of gout, diabetes, high cholesterol, lupus, or kidney or liver disease, these conditions don’t necessarily rule out chlorthalidone, but they require careful monitoring and may influence whether your doctor chooses this drug over alternatives.
Chlorthalidone should not be taken during breastfeeding. Pregnant women or those planning pregnancy should discuss the risks with their doctor, as the medication can affect the developing baby.
Important Drug Interactions
One of the most serious interactions involves lithium, a medication used for bipolar disorder. Chlorthalidone and other thiazide diuretics reduce the kidneys’ ability to clear lithium from the body, causing lithium levels to rise. Since lithium has a very narrow window between a therapeutic dose and a toxic one, even a small increase in blood levels can cause serious problems, including tremors, confusion, and kidney damage. If you take lithium and need a diuretic, your doctor will monitor lithium levels closely and may adjust your dose.
Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen can blunt chlorthalidone’s blood-pressure-lowering effect by promoting sodium and water retention in the kidneys. Occasional use is generally fine, but regular NSAID use alongside chlorthalidone can undermine the very reason you’re taking the medication.